Laura Bianchi, Rose Law Group partner and director of Medical Cannabis, talks to ‘Scottsdale Independent’ about medical marijuana and investment

Laura Bianchi

By Terrance Thornton | Scottsdale Independent

As Americans begin to come to terms with the ill effects of the pharmaceutical smörgåsbord offered for minor ailments to advanced critical illness, a new commodity is beginning to emerge in towns and cities across the nation.

From alternatives of the go-to-pain prescription — the opioid — and the shifting of perspectives, depending on who you ask, a new miracle drug is emerging: THC.

THC, which is short for tetrahydrocannabinol, is the principal psychoactive constituent of cannabis. In 1996, California became the first state to legalize medical cannabis, sparking a trend that has now touched many states.

Pills like this hydrocodone tablet are many peoples’ first introduction to the world of opiods that, in recent years, has translated into addiction, death and destruction. (file photo)

In 2016, 790 Arizonans died from opioid overdoses while zero deaths have been reported in Arizona as a result of medical marijuana use despite a rampant up-tick to those who seek the naturally occurring herb for consumption on a legal basis.

READ ON:

Share this!

Additional Articles

Rose Law Group pc values “outrageous client service.” We pride ourselves on hyper-responsiveness to our clients’ needs and an extraordinary record of success in achieving our clients’ goals. We know we get results and our list of outstanding clients speaks to the quality of our work.

News Categories